Fund Holdings — Rhenman & Partners Asset Management AB

Total Portfolio Value:
$791.02M
Total Bought:
$162.99M
Total Sold:
$248.84M
Net Transaction:
-$85.84M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Eli Lilly and Company(LLY)41,75057,870+16,120$34.48M$45.11M5.70%+$10.63M
Boston Scientific Corporation(BSX)300,000296,000-4,000$30.26M$31.79M4.02%+$1.53M
Vertex Pharmaceuticals Incorporated(VRTX)66,75061,455-5,295$32.36M$27.36M3.46%-$5.00M
Glaukos Corporation(GKOS)270,000235,000-35,000$26.57M$24.27M3.07%-$2.30M
Intuitive Surgical, Inc.(ISRG)51,50044,350-7,150$25.51M$24.10M3.05%-$1.41M
Tenet Healthcare Corporation(THC)126,700136,429+9,729$17.04M$24.01M3.04%+$6.97M
Danaher Corporation(DHR)41,952121,452+79,500$8.60M$23.99M3.03%+$15.39M
CVS Health Corporation(CVS)235,862295,362+59,500$15.98M$20.37M2.58%+$4.39M
McKesson Corporation(MCK)47,21727,717-19,500$31.78M$20.31M2.57%-$11.47M
Neurocrine Biosciences, Inc.(NBIX)89,817149,217+59,400$9.93M$18.76M2.37%+$8.82M
Gilead Sciences, Inc.(GILD)233,500168,150-65,350$26.16M$18.64M2.36%-$7.52M
Endeavour Silver Corp.(EXK)440,000350,000-90,000$19.05M$18.60M2.35%-$448.6K
Alignment Healthcare, Inc.(ALHC)1,337,2841,287,284-50,000$24.90M$18.02M2.28%-$6.88M
Insmed Incorporated(INSM)185,500175,435-10,065$14.15M$17.66M2.23%+$3.50M
Elevance Health, Inc.(ELV)48,95044,650-4,300$21.29M$17.37M2.20%-$3.92M
Encompass Health Corporation(EHC)37,400136,400+99,000$3.79M$16.73M2.11%+$12.94M
Alnylam Pharmaceuticals, Inc.(ALNY)48,19751,197+3,000$13.01M$16.69M2.11%+$3.68M
Medtronic plcSHS(MDT)255,000179,500-75,500$22.91M$15.65M1.98%-$7.27M
Cencora Inc32,37549,375+17,000$9.00M$14.81M1.87%+$5.80M
Regeneron Pharmaceuticals, Inc.(REGN)31,75027,700-4,050$20.14M$14.54M1.84%-$5.59M
Insulet Corporation(PODD)61,00046,000-15,000$16.02M$14.45M1.83%-$1.57M
DexCom, Inc.(DXCM)155,000159,500+4,500$10.58M$13.92M1.76%+$3.34M
AbbVie Inc.(ABBV)88,65069,375-19,275$18.57M$12.88M1.63%-$5.70M
Align Technology Inc41,50066,500+25,000$6.59M$12.59M1.59%+$6.00M
Royalty Pharma plcCL A(RPRX)411,000344,000-67,000$12.79M$12.39M1.57%-$400.1K
The Cooper Companies, Inc.(COO)236,000170,000-66,000$19.91M$12.10M1.53%-$7.81M
Jazz Pharmaceuticals plcSHS USD(JAZZ)124,300109,030-15,270$15.43M$11.57M1.46%-$3.86M
HCA Healthcare, Inc.(HCA)16,77829,778+13,000$5.80M$11.41M1.44%+$5.61M
PROCEPT BioRobotics Corporation(PRCT)448,000190,000-258,000$26.10M$10.94M1.38%-$15.16M
The Cigna Group(CI)28,20032,000+3,800$9.28M$10.58M1.34%+$1.30M
Akero Therapeutics Inc92,500197,600+105,100$3.74M$10.54M1.33%+$6.80M
Verona Pharma PlcADS70,000106,500+36,500$4.44M$10.07M1.27%+$5.63M
Natera, Inc.(NTRA)138,50057,500-81,000$19.59M$9.71M1.23%-$9.87M
UnitedHealth Group Incorporated(UNH)77,43030,430-47,000$40.55M$9.49M1.20%-$31.06M
Axsome Therapeutics, Inc.(AXSM)109,60090,800-18,800$12.78M$9.48M1.20%-$3.30M
Cardinal Health, Inc.(CAH)055,000+55,000$0$9.24M1.17%+$9.24M
BioMarin Pharmaceutical Inc.(BMRN)265,000149,650-115,350$18.73M$8.23M1.04%-$10.51M
Abbott Labs52,00058,500+6,500$6.90M$7.96M1.01%+$1.06M
Ionis Pharmaceuticals, Inc.(IONS)81,000182,000+101,000$2.44M$7.19M0.91%+$4.75M
Oscar Health, Inc.CL A(OSCR)1,022,743312,092-710,651$13.41M$6.69M0.85%-$6.72M
Molina Healthcare, Inc.(MOH)68,20022,200-46,000$22.46M$6.61M0.84%-$15.85M
Merus N V74,500116,000+41,500$3.14M$6.10M0.77%+$2.97M
Alcon Inc.(ALC)068,000+68,000$0$5.99M0.76%+$5.99M
Dynavax Technologies Corp565,000565,0000$7.33M$5.60M0.71%-$1.72M
Penumbra, Inc.(PEN)2,20021,500+19,300$588.3K$5.52M0.70%+$4.93M
Centene Corporation(CNC)126,00099,757-26,243$7.65M$5.41M0.68%-$2.23M
Syndax Pharmaceuticals, Inc.(SNDX)433,000574,000+141,000$5.32M$5.38M0.68%+$56.1K
Bruker Corporation(BRKR)42,315123,315+81,000$1.77M$5.08M0.64%+$3.31M
Anteris Technologies Global Corp.(AVR)1,290,0001,250,763-39,237$4.70M$4.74M0.60%+$44.8K
Astrana Health, Inc.(ASTH)150,000190,000+40,000$4.65M$4.73M0.60%+$75.7K
Universal Health Services, Inc.CL B(UHS)026,000+26,000$0$4.71M0.60%+$4.71M
Stryker Corporation(SYK)011,500+11,500$0$4.55M0.58%+$4.55M
Thermo Fisher Scientific Inc.(TMO)12,64011,140-1,500$6.29M$4.52M0.57%-$1.77M
Arcellx Inc
COMMON STOCK
43,50067,250+23,750$2.85M$4.43M0.56%+$1.57M
Edwards Lifesciences Corp055,000+55,000$0$4.30M0.54%+$4.30M
TG Therapeutics, Inc.(TGTX)177,500115,000-62,500$7.00M$4.14M0.52%-$2.86M
Nuvalent Inc52,50052,5000$3.72M$4.01M0.51%+$282.4K
Inspire Medical Systems, Inc.(INSP)16,00030,500+14,500$2.55M$3.96M0.50%+$1.41M
BioNTech SEADS(BNTX)35,75035,870+120$3.26M$3.82M0.48%+$563.7K
Cytokinetics, Incorporated(CYTK)104,250104,2500$4.19M$3.44M0.44%-$745.4K
Ultragenyx Pharmaceutical Inc.(RARE)82,00093,100+11,100$2.97M$3.39M0.43%+$415.9K
Mirum Pharmaceuticals, Inc.(MIRM)73,75565,755-8,000$3.32M$3.35M0.42%+$23.6K
Structure Therapeutics IncADS70,000135,100+65,100$1.21M$2.80M0.35%+$1.59M
RadNet, Inc.(RDNT)046,000+46,000$0$2.62M0.33%+$2.62M
Vericel Corporation(VCEL)058,000+58,000$0$2.47M0.31%+$2.47M
Repligen Corporation(RGEN)4,50019,500+15,000$572.6K$2.43M0.31%+$1.85M
LivaNova PLCSHS(LIVN)053,000+53,000$0$2.39M0.30%+$2.39M
Dianthus Therapeutics, Inc.(DNTH)126,627126,6270$2.30M$2.36M0.30%+$62.0K
Viking Therapeutics, Inc.(VKTX)100,00085,000-15,000$2.42M$2.25M0.28%-$162.5K
MoonLake ImmunotherapeuticsCL A(MLTX)45,00045,0000$1.76M$2.12M0.27%+$365.9K
Nurix Therapeutics, Inc.(NRIX)249,336185,000-64,336$2.96M$2.11M0.27%-$855.0K
Privia Health Group, Inc.(PRVA)98,18991,189-7,000$2.20M$2.10M0.27%-$107.0K
IQVIA Holdings Inc.(IQV)22,00013,000-9,000$3.88M$2.05M0.26%-$1.83M
Krystal Biotech, Inc.(KRYS)17,75012,750-5,000$3.20M$1.75M0.22%-$1.45M
Summit Therapeutics Inc.(SMMT)078,000+78,000$0$1.66M0.21%+$1.66M
Apellis Pharmaceuticals Inc
COM
28,25093,250+65,000$617.8K$1.61M0.20%+$996.3K
Relay Therapeutics, Inc.(RLAY)460,000460,0000$1.21M$1.59M0.20%+$386.4K
Biogen Inc.(BIIB)49,50012,000-37,500$6.77M$1.51M0.19%-$5.27M
Kura Oncology, Inc.(KURA)195,000250,000+55,000$1.29M$1.44M0.18%+$155.5K
Denali Therapeutics Inc.(DNLI)100,000100,0000$1.36M$1.40M0.18%+$39.5K
Xencor, Inc.(XNCR)195,750165,750-30,000$2.08M$1.30M0.16%-$780.0K
Doximity, Inc.CL A(DOCS)021,000+21,000$0$1.29M0.16%+$1.29M
Janux Therapeutics, Inc.(JANX)141,62755,127-86,500$3.82M$1.27M0.16%-$2.55M
Alkermes plcSHS(ALKS)39,00039,0000$1.29M$1.12M0.14%-$172.0K
Iovance Biotherapeutics, Inc.(IOVA)647,827647,8270$2.16M$1.11M0.14%-$1.04M
Annexon, Inc.(ANNX)460,000460,0000$887.8K$1.10M0.14%+$216.2K
Xenon Pharmaceuticals Inc.(XENE)35,00035,0000$1.17M$1.10M0.14%-$78.8K
Immunocore Holdings plcADS(IMCR)28,27828,2780$839.0K$887.4K0.11%+$48.4K
Bio-Techne Corporation(TECH)015,000+15,000$0$771.8K0.10%+$771.8K
INmune Bio Inc.(INMB)178,284178,2840$1.39M$411.8K0.05%-$980.6K
Amgen Inc.(AMGN)4,0000-4,000$1.25M$0—-$1.25M
Arvinas, Inc.(ARVN)183,0000-183,000$1.28M$0—-$1.28M
Avantor, Inc.(AVTR)47,8260-47,826$775.3K$0—-$775.3K
Becton, Dickinson and Company(BDX)19,0000-19,000$4.35M$0—-$4.35M
Bristol-Myers Squibb Company(BMY)325,0000-325,000$19.82M$0—-$19.82M
Esperion Therapeutics Inc Ne1,066,4950-1,066,495$1.54M$0—-$1.54M
Geron Corporation(GERN)783,0000-783,000$1.24M$0—-$1.24M
Humana Inc.(HUM)46,8300-46,830$12.39M$0—-$12.39M
ICON Public Limited CompanySHS(ICLR)7,0000-7,000$1.22M$0—-$1.22M
IDEAYA Biosciences, Inc.(IDYA)39,5000-39,500$647.0K$0—-$647.0K
Page 1 of 2
Rhenman & Partners Asset Management AB — 13F Holdings — Q2 2025 | TickerTrail